An innovative home rehabilitation program for people with traumatic brain injury and their families
Official title: A randomized controlled trial of an innovative in-home rehabilitation program for persons with TBI and their families: Home-based Occupational-therapy and Management of the Environment (HOME for Us)
Funded at Villanova University · NIH-10861877 · Data updated 2026-11-12
This study is testing a new home-based program called HOME for Us, which helps people with ongoing challenges from traumatic brain injury (TBI) and their families by having occupational therapists work with them at home to improve their daily lives and support their caregivers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Villanova University NIH-funded |
| Lab location | 1 site (Villanova, United States) |
| Project start | September 15, 2020 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $608,664 |
| NIH project number | 5R01NR018655-05 |
| Project ID | NIH-10861877 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced a traumatic brain injury more than one year ago and are struggling with ongoing symptoms.
✕Less likely to help
Patients who have recently sustained a TBI (within the past year) or those without chronic symptoms may not benefit from this research.
What this research studies
This research investigates a new home-based rehabilitation program designed for individuals with chronic symptoms from traumatic brain injury (TBI) and their families. The program, called HOME for Us, involves occupational therapists working directly in patients' homes over four months to help them manage TBI-related challenges and improve their quality of life. By focusing on the environment and personal needs, the program aims to enhance community reintegration and support family caregivers who often face significant burdens. Participants will engage in eight sessions tailored to their specific situations and goals.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for individuals with TBI and their families by providing effective management strategies for chronic symptoms.
How similar studies have gone: Previous research has shown promise in home-based rehabilitation approaches for chronic conditions, suggesting that this innovative method could be effective.
Where this research is happening
-
Villanova University
Villanova, United States Active
Researchers
- Principal investigator: Moriarty, Helene Joy — Villanova University
- Study coordinator: Moriarty, Helene Joy
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.